(State or other jurisdiction of incorporation) |
(Commission file number) |
(I.R.S. employer identification no.) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Press Release dated May 10, 2022 of TransAct Technologies Incorporated |
||
104 |
Cover page from this Current Report on Form 8-K, formatted in Inline XBRL |
TRANSACT TECHNOLOGIES INCORPORATED |
|||||
By: |
/s/ David B. Peters |
||||
David B. Peters |
|||||
Vice President & Chief Accounting Officer |
•
|
Net
Sales: Net sales for the first quarter of 2022 were $9.7 million, up 17% compared to $8.3 million for the first quarter of 2021.
|
•
|
FST
Recurring Revenue: FST recurring revenue for the first quarter of 2022 was $1.6 million, up 30% compared to $1.2 million for the first quarter of 2021.
|
•
|
Gross
Profit: Gross profit for the first quarter of 2022 was $3.0 million, resulting in gross margin of 30.9%, compared to gross profit of $3.2 million for the first quarter of 2021, which resulted in a 38.4% gross margin.
|
•
|
Operating
loss: Operating loss for the first quarter of 2022 was $(5.2) million, compared to operating loss of $(2.7) million for the first quarter of 2021.
|
•
|
Net
loss: Net loss for the first quarter of 2022 was $(4.0) million, or $(0.41) net loss per diluted share, based on 9.9 million weighted average common shares outstanding. Net loss for the comparable 2021 period was $(2.2) million, or
$(0.25) net loss per diluted share, based on 8.9 million weighted average common shares outstanding.
|
•
|
EBITDA:
EBITDA loss was $(5.0) million for the first quarter of 2022, compared to an EBITDA loss of $(2.5) million for the first quarter of 2021.
|
•
|
Adjusted
EBITDA loss: Adjusted EBITDA loss was $(4.7) million for the first quarter of 2022, compared to adjusted EBITDA loss of $(2.2) million for the first quarter of 2021.
|
•
|
Paid Terminals: Paid terminals in the market were 10,127 on March 31, 2022, compared to 7,009 on March 31, 2021, an increase of 44%.
|
Bart Shuldman
Chief Executive Officer
TransAct Technologies Incorporated
|
Ryan Gardella
ICR, Inc.
Ryan.Gardella@ircinc.com
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||
(Preliminary and Unaudited)
|
||||||||
Three months ended
March 31, |
||||||||
2022
|
2021
|
|||||||
(In thousands, except per share data)
|
||||||||
Net sales
|
$
|
9,702
|
$
|
8,301
|
||||
Cost of sales
|
6,708
|
5,112
|
||||||
Gross profit
|
2,994
|
3,189
|
||||||
Operating expenses:
|
||||||||
Engineering, design and product development
|
2,283
|
1,803
|
||||||
Selling and marketing
|
2,683
|
1,443
|
||||||
General and administrative
|
3,204
|
2,609
|
||||||
8,170
|
5,855
|
|||||||
Operating loss
|
(5,176
|
)
|
(2,666
|
)
|
||||
Interest and other expense:
|
||||||||
Interest, net
|
(64
|
)
|
(13
|
)
|
||||
Other, net
|
(35
|
)
|
(83
|
)
|
||||
(99
|
)
|
(96
|
)
|
|||||
Loss before income taxes
|
(5,275
|
)
|
(2,762
|
)
|
||||
Income tax benefit
|
1,262
|
556
|
||||||
Net loss
|
$
|
(4,013
|
)
|
$
|
(2,206
|
)
|
||
Net loss per common share:
|
||||||||
Basic
|
$
|
(0.41
|
)
|
$
|
(0.25
|
)
|
||
Diluted
|
$
|
(0.41
|
)
|
$
|
(0.25
|
)
|
||
Shares used in per share calculation:
|
||||||||
Basic
|
9,886
|
8,948
|
||||||
Diluted
|
9,886
|
8,948
|
SUPPLEMENTAL INFORMATION – SALES BY MARKET:
(Preliminary and Unaudited)
|
||||||||
Three months ended
March 31, |
||||||||
2022
|
2021
|
|||||||
(In thousands)
|
||||||||
Food service technology
|
$
|
2,130
|
$
|
2,747
|
||||
POS automation
|
1,300
|
1,164
|
||||||
Casino and gaming
|
4,762
|
2,865
|
||||||
Printrex
|
-
|
159
|
||||||
TransAct services group
|
1,510
|
1,366
|
||||||
Total net sales
|
$
|
9,702
|
$
|
8,301
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS
|
||||||||
(Preliminary and Unaudited)
|
||||||||
March 31,
|
December 31,
|
|||||||
2022
|
2021
|
|||||||
Assets:
|
(In thousands)
|
|||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
11,994
|
$
|
19,457
|
||||
Accounts receivable, net
|
6,882
|
7,593
|
||||||
Employee retention credit receivable
|
1,500
|
1,500
|
||||||
Inventories
|
9,048
|
7,720
|
||||||
Prepaid income taxes
|
142
|
137
|
||||||
Other current assets
|
1,579
|
738
|
||||||
Total current assets
|
31,145
|
37,145
|
||||||
Fixed assets, net
|
3,100
|
2,684
|
||||||
Right-of-use asset
|
2,349
|
2,553
|
||||||
Goodwill
|
2,621
|
2,621
|
||||||
Deferred tax assets
|
6,402
|
5,141
|
||||||
Intangible assets, net
|
358
|
397
|
||||||
Other assets
|
308
|
400
|
||||||
15,138
|
13,796
|
|||||||
Total assets
|
$
|
46,283
|
$
|
50,941
|
||||
Liabilities and Shareholders’ Equity:
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
3,997
|
$
|
4,308
|
||||
Accrued liabilities
|
3,631
|
3,894
|
||||||
Lease liability
|
744
|
789
|
||||||
Deferred revenue
|
823
|
805
|
||||||
Total current liabilities
|
9,195
|
9,796
|
||||||
Deferred revenue, net of current portion
|
171
|
186
|
||||||
Lease liability, net of current portion
|
1,617
|
1,781
|
||||||
Other liabilities
|
187
|
187
|
||||||
1,975
|
2,154
|
|||||||
Total liabilities
|
11,170
|
11,950
|
||||||
Shareholders’ equity:
|
||||||||
Common stock
|
139
|
139
|
||||||
Additional paid-in capital
|
55,423
|
55,246
|
||||||
Retained earnings
|
11,560
|
15,573
|
||||||
Accumulated other comprehensive income, net of tax
|
101
|
143
|
||||||
Treasury stock, at cost
|
(32,110
|
)
|
(32,110
|
)
|
||||
Total shareholders’ equity
|
35,113
|
38,991
|
||||||
Total liabilities and shareholders’ equity
|
$
|
46,283
|
$
|
50,941
|
||||
TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF NET LOSS TO EBITA AND ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited)
|
||||||||
Three months ended
March 31, |
||||||||
2022
|
2021
|
|||||||
(In thousands)
|
||||||||
Net loss |
$
|
(4,013)
|
$
|
(2,206)
|
||||
Interest expense, net |
64 |
13 |
||||||
Income tax benefit |
(1,262) |
(556) |
||||||
Depreciation and amortization |
228 |
240 |
||||||
EBITDA | (4,983) |
(2,509) | ||||||
Share-based compensation expenses |
296 |
264 |
||||||
Adjusted EBITDA |
$ | (4,687) | $ | (2,245) |